Open AccessNovel model combining contrast-enhanced ultrasound with serology predicts hepatocellular carcinoma recurrence after hepatectomy
Author(s) -
Haibin Tu,
Lihong Chen,
Yu-Jie Huang,
Siyi Feng,
Jian-Ling Lin,
Yongyi Zeng
Publication year - 2021
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v9.i24.7009
Subject(s) - medicine , hepatocellular carcinoma , hepatectomy , contrast enhanced ultrasound , serology , ultrasound , radiology , oncology , resection , surgery , antibody , immunology
Surgery is the primary curative option in patients with hepatocellular carcinoma (HCC). However, recurrence within 2 years is observed in 30%-50% of patients, being a major cause of mortality.